Generally, given the lack of gain-of-function KIT and PDGFRA mutations, SDH-deficient GISTs are widely considered resistant to all tyrosine kinase inhibitors (TKIs), as all other KIT/PDGFRA WT GIST. Here, SDHB is linked to gastrointestinal stromal tumor.